Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
LGC Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
LGC Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
LGC Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
LGC Ltd, Medical Devices Deals, 2012 to YTD 2018 9
LGC Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
LGC Ltd, Pharmaceuticals & Healthcare, Deal Details 11
Asset Purchase 11
LGC Genomics To Acquire Bioanalytical Sciences Business Of Quotient BioResearch 11
Venture Financing 12
Lucigen Raises USD2.2 Million in Venture Financing 12
Lucigen Raises USD1.95 Million in Venture Financing 13
Lucigen Raises US$1.7 Million In Venture Financing 14
Private Equity 15
KKR to Acquire LGC from Bridgepoint 15
Partnerships 16
Lucigen Enters into Distribution Agreement with Illumina 16
Lucigen Enters into Distribution Agreement with Sigma-Aldrich 17
EnviroLogix Enters Into Distribution Agreement With Douglas Scientific 18
Lucigen Enters Into Distribution Agreement With Research Corporation Technologies For Endotoxin Free CleanColi Expression System 19
Link Technologies Enters Into Distribution Agreement With GeneDesign 20
ChromaDex Enters Into Distribution Agreement With LGC Standards For LoGiCal Reference Standards 21
EnviroLogix Enters Into Co-Development Agreement With Douglas Scientific 22
Life Technologies Enters Into Co-Marketing Agreement With Douglas Scientific 23
Licensing Agreements 24
LGC Enters into Licensing Agreement with Keygene 24
Biosearch Technologies Enters Into Licensing Agreement With Rutgers University For turboFISH Technology 25
Biosearch Technologies Enters Into Licensing Agreement With University of Medicine and Dentistry of New Jersey For Nucleic Acid Probe Technology 26
Acquisition 27
LGC Acquires Axolabs 27
LGC to Acquire Biosearch Technologies 28
Biosearch Technologies Acquires Majority Stake In LightSpeed Genomics 29
LGC Ltd – Key Competitors 30
LGC Ltd – Key Employees 31
LGC Ltd – Locations And Subsidiaries 32
Head Office 32
Other Locations & Subsidiaries 32
Joint Venture 33
Recent Developments 34
Corporate Communications 34
Sep 22, 2017: Dr. Juergen Mueller joins LGC as Commercial and Strategic Development Director, Oligo-therapeutics 34
Legal and Regulatory 35
Jul 03, 2018: NML awarded ISO17025 accreditation for digital PCR-based quantification of DNA 35
Product News 36
Jul 05, 2017: Meridian2 delivers high throughput liquid handling for PCR 36
Jan 16, 2017: Hydrocycler2 delivers high throughput thermal cycling for PCR 37
Appendix 38
Methodology 38
About GlobalData 38
Contact Us 38
Disclaimer 38
LGC Ltd, Pharmaceuticals & Healthcare, Key Facts, 2017 2
LGC Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 2
LGC Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
LGC Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
LGC Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
LGC Ltd, Medical Devices Deals, 2012 to YTD 2018 9
LGC Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
LGC Genomics To Acquire Bioanalytical Sciences Business Of Quotient BioResearch 11
Lucigen Raises USD2.2 Million in Venture Financing 12
Lucigen Raises USD1.95 Million in Venture Financing 13
Lucigen Raises US$1.7 Million In Venture Financing 14
KKR to Acquire LGC from Bridgepoint 15
Lucigen Enters into Distribution Agreement with Illumina 16
Lucigen Enters into Distribution Agreement with Sigma-Aldrich 17
EnviroLogix Enters Into Distribution Agreement With Douglas Scientific 18
Lucigen Enters Into Distribution Agreement With Research Corporation Technologies For Endotoxin Free CleanColi Expression System 19
Link Technologies Enters Into Distribution Agreement With GeneDesign 20
ChromaDex Enters Into Distribution Agreement With LGC Standards For LoGiCal Reference Standards 21
EnviroLogix Enters Into Co-Development Agreement With Douglas Scientific 22
Life Technologies Enters Into Co-Marketing Agreement With Douglas Scientific 23
LGC Enters into Licensing Agreement with Keygene 24
Biosearch Technologies Enters Into Licensing Agreement With Rutgers University For turboFISH Technology 25
Biosearch Technologies Enters Into Licensing Agreement With University of Medicine and Dentistry of New Jersey For Nucleic Acid Probe Technology 26
LGC Acquires Axolabs 27
LGC to Acquire Biosearch Technologies 28
Biosearch Technologies Acquires Majority Stake In LightSpeed Genomics 29
LGC Ltd, Key Competitors 30
LGC Ltd, Key Employees 31
LGC Ltd, Other Locations 32
LGC Ltd, Subsidiaries 32
LGC Ltd, Joint Venture 33
List of Figures
LGC Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
LGC Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
LGC Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
LGC Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
LGC Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7
LGC Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
LGC Ltd, Medical Devices Deals, 2012 to YTD 2018 9
【免責事項】
http://www.globalresearch.jp/disclaimer